EUVIMEDEUVIMED entdecken
Crossref

Validation of Radiosynthesis and First in-Human Dosimetry of 68 Ga-NOTA-UBI-29-41: A Proof of Concept Study

Parul Thakral, Nishant Rana, Navneet Singh, Subha Shankar Das, Mrinalini Koley, Jatin Gupta, Dharmender Malik, Ishita Sen iD

Cancer Biotherapy and Radiopharmaceuticals · 2025

DOI: 10.1089/cbr.2024.0082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2025. Verfasst von Parul Thakral und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurugram, India. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Radiopharmaceuticals, Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial peptides (AMPs) such as UBI-29-41 offer a distinctive approach for precise detection due to their unique interactions with bacteria and makes them promising candidates for specific and selective imaging. The study was aimed to corroborate the in-house manual synthesis of 68Ga-NOTA-UBI-29-41, evaluate its uptake in patients with suspected infection, and estimate of patient-specific dosimetry to ensure optimal clinical application. Materials and Methods: 68Ga-NOTA-UBI-29-41 was synthesized by using a variable amount of UBI-29-41 (60-90 μg) to 555 MBq of 68Ga in 0.05 M hydrochloric acid (HCl) and heating the reaction sample for 12 min at 90°C at pH: 3.5-4 to obtain the radiopeptide with high yield and high radiochemical purity (RCP). 68Ga-NOTA-UBI-29-41 positron emission tomography/computed tomography (PET/CT) scans at variable timepoints were done to evaluate its biodistribution and maximum uptake time. Furthermore, patient-specific dosimetric estimation was done using the HERMES software.

Results

A total of 5 μg/37 MBq (5 μg/mCi) of NOTA-UBI-29-41 for 12 min at 90°C were the optimal parameters to obtain 88%-90% of yield and 98%-99 % of RCP. 68Ga-NOTA-UBI-29-41 showed expeditious blood clearance and high renal excretion. The optimal time for imaging of infection with 68Ga-NOTA-UBI-29-41 was found to be at 60 min postinjection (n = 8). The critical organ was the urinary bladder, receiving an average dose of 138.02 ± 45.92 µSv/MBq, followed by 53.81 ± 13.72 µSv/MBq for kidneys with a mean effective dose of 1.52 ± 0.64 mSv.

Conclusion

The protocol for in-house manual labeling of 68Ga-NOTA-UBI-29-41 was reproducible, providing high yield and RCP. 68Ga-NOTA-UBI-29-41 administration was found to be safe and nontoxic. The favorable biodistribution and the first-in-human patient-specific dosimetry ensure optimal clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesRadiopharmaceuticalsHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHumansTissue DistributionRadiometryProof of Concept StudyPositron Emission Tomography Computed Tomography

Stichwörter der Autor:innen

68Ga-NOTA-UBI-29-41antimicrobial peptidesimage-based dosimetryinfection imagingradiosynthesis

Substanzen

Gallium RadioisotopesRadiopharmaceuticalsHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurugram, India.

ORCID-Profile: Ishita Sen

Zitieren

APA

Thakral, P., Rana, N., Singh, N., Das, S. S., Koley, M., Gupta, J., Malik, D., & Sen, I. (2025). Validation of Radiosynthesis and First in-Human Dosimetry of 68 Ga-NOTA-UBI-29-41: A Proof of Concept Study. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2024.0082

Vancouver

Thakral P, Rana N, Singh N, Das SS, Koley M, Gupta J, et al. Validation of Radiosynthesis and First in-Human Dosimetry of 68 Ga-NOTA-UBI-29-41: A Proof of Concept Study. Cancer Biotherapy and Radiopharmaceuticals. 2025. doi:10.1089/cbr.2024.0082

BibTeX
@article{Thakral2025,
  author = {Thakral, Parul and Rana, Nishant and Singh, Navneet and Das, Subha Shankar and Koley, Mrinalini and Gupta, Jatin and Malik, Dharmender and Sen, Ishita},
  title = {Validation of Radiosynthesis and First in-Human Dosimetry of 68 Ga-NOTA-UBI-29-41: A Proof of Concept Study},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2025},
  doi = {10.1089/cbr.2024.0082}
}
Kostenlos starten →